Brain wave test to guide ADHD medication choice
Part of Mental health clinical trials.
This study tests whether brain wave recordings (EEG) can help predict how well children with ADHD will respond to stimulant medications. It aims to find the best treatment faster, potentially reducing the guesswork in choosing the right medication.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be between 7 and 10 years old.
- They must have (or be getting evaluated for) ADHD.
- They should not have taken stimulants for very long before (less than 6 months of total use), and they need to stop any such medications at least 1 week before the study starts.
- Their ADHD symptoms should be moderate to severe.
- They cannot have certain other conditions like autism, intellectual disability, heart problems, or a history of seizures.
- Females who are able to get pregnant cannot be pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how ADHD medications and small head movements during brain scans affect attention. It may help researchers understand how these medicines work, which could improve ADHD care.
This trial tests if a noninvasive brain stimulation treatment (accelerated iTBS) can improve working memory or impulse control in adolescents with ADHD. It involves MRI scans and TMS sessions to see which thinking skill benefits most.
This Phase 4 study looks at how to manage ADHD symptoms in children and teens who also have autism. It may help your child’s care team learn what treatment routines work best in real life settings.
This trial tests a non-invasive brain stimulation treatment (called rTMS) to see if it can help reduce ADHD symptoms in children and adolescents. It may offer an additional treatment option beyond medication.
This study looks at how the brain's electrical activity may predict whether a child with ADHD will respond well to methylphenidate (Ritalin). It aims to find biological markers that could help doctors choose the right treatment sooner.
This Phase 4 study checks whether certain markers change in the brain/body when children with ADHD take methylphenidate (a stimulant). It also compares these markers with healthy children to better understand ADHD.
Hear when a new ADHD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.